anti-cfa/i bovine igg
Animal productexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00435526)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Escherichia coliImmunity, passive
Escherichia coli immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- anti-cfa/i bovine igg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00435526 | Phase 1 | Mar 1, 2006 | Johns Hopkins University, United States Army, United States Navy |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| United States Army | Government | 1 | 0 | 1 | 2006 |
| United States Navy | Government | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1